Autolus Therapeutics (AUTL) Other Non Operating Income (2017 - 2026)

Autolus Therapeutics (AUTL) has 9 years of Other Non Operating Income data on file, last reported at $400000.0 in Q4 2025.

• Quarterly Other Non Operating Income fell 96.49% year-over-year to $400000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.2 million (up 461.82% YoY) and the FY2025 annual result came in at $2.2 million, up 320.0% from the prior year.
• Other Non Operating Income climbed to $400000.0 in Q4 2025, from -$911000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $11.4 million in Q4 2024 to a low of -$11.9 million in Q3 2024.
• A 5-year average of $304550.0 and a median of $632000.0 in 2023 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2022 — Other Non Operating Income soared 7369.77% — and 2024, when it tumbled 586.67%.
• Tracing AUTL's Other Non Operating Income over 5 years: stood at -$86000.0 in 2021, then soared by 7369.77% to $6.3 million in 2022, then sank by 50.72% to $3.1 million in 2023, then surged by 270.01% to $11.4 million in 2024, then tumbled by 96.49% to $400000.0 in 2025.
• The last three Other Non Operating Income figures came in at $400000.0 (Q4 2025), -$911000.0 (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.